IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases. Founded by Anil K. Goyal in 2017, IMMvention Therapeutix is backed by investors that include North Carolina Biotechnology Center and is headquartered in Chapel Hill.
FOUNDED:
2017
INDUSTRY:
Biotechnology, Health Care, Therapeutics
FOUNDERS:
Anil K. Goyal
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
